About
Respira Therapeutics is a clinical-stage company developing next-generation inhaled therapies targeting cardiopulmonary diseases, including pulmonary arterial hypertension, using advanced drug formulation and delivery technologies.
Explore Respira Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.